Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$363K Sell
5,571
-295
-5% -$20.6K 0.21% 117
2022
Q1
$451K Sell
5,866
-2,249
-28% -$165K 0.13% 201
2021
Q4
$628K Sell
8,115
-3,484
-30% -$245K 0.15% 149
2021
Q3
$732K Sell
11,599
-2,618
-18% -$167K 0.18% 127
2021
Q2
$889K Buy
+14,217
New +$929K 0.2% 102

Other funds holding ACM

Exane Derivatives's ACM Position: Q2 2022 in Review

Exane Derivatives reduced its Aecom (ACM) stake by 5% in Q2 2022, selling an estimated $20.6K and leaving 5,571 shares worth $363K. The position accounts for 0.21% of the portfolio, ranked #117.

Exane Derivatives first reported a position in ACM in Q2 2021 and has held it in 5 quarters since. The position peaked at $889K in Q2 2021. 365 funds tracked by Wall St. Rank hold ACM as of Q2 2022.

  • Exane Derivatives held 5,571 shares of Aecom worth $363K as of Q2 2022.
  • Exane Derivatives sold 295 Aecom shares in Q2 2022, an estimated $20.6K.
  • Aecom made up 0.21% of Exane Derivatives's portfolio in Q2 2022, its #117 holding.
  • Exane Derivatives first reported a position in Aecom in Q2 2021 and has held it in 5 quarters since.
  • Exane Derivatives's Aecom position peaked at $889K in Q2 2021.
  • 365 funds tracked by Wall St. Rank held Aecom as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.